HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matriptase and survivin expression associated with tumor progression and malignant potential in breast cancer of Chinese women: tissue microarray analysis of immunostaining scores with clinicopathological parameters.

AbstractOBJECTIVE:
The aim of this study was to examine the expression of matriptase and survivin in breast carcinoma and correlate with clinicopathological parameters.
METHODS:
Immunohistochemical analysis of matriptase and survivin were performed in tissue microarray slides of 290 cases, including 11 normal breast tissue; 27 fibrocystic disease; 17 fibroadenoma; 6 atypical ductal hyperplasia; 39 ductal carcinoma in situ, low grade (DCIS, low grade); 39 ductal carcinoma in situ, high grade (DCIS, high grade); 27 invasive ductal carcinoma, grade I (IDC, grade I); 78 invasive ductal carcinoma, grade II (IDC, grade II); and 46 invasive ductal carcinoma, grade III (IDC, grade III).
RESULTS:
The average immunostaining scores of matriptase were 44.1 in normal breast tissue, 52.7 in fibrocystic disease, 76.5 in fibroadenoma, 81.7 in atypical ductal hyperplasia, 133.7 in low-grade DCIS, and 155.8 in high-grade DCIS. Among 151 breast IDC cases, the average immunostaining scores of matriptase were 172.7 in grade I, 211.7 in grade II, and 221.2 in grade III. Additionally, the average immunostaining scores of surviving also correlate with tumor grades and stages.
CONCLUSIONS:
Higher expressions of matriptase and survivin correlate significantly with clinicopathological parameters in breast cancer and the malignant potential in premalignant lesions. In addition, higher survivin expression had poorer prognosis of breast IDC cases.
AuthorsWen-Chiuan Tsai, Chi-Hong Chu, Cheng-Pin Yu, Lai-Fa Sheu, Ann Chen, Hung Chiang, Jong-Shiaw Jin
JournalDisease markers (Dis Markers) Vol. 24 Issue 2 Pg. 89-99 ( 2008) ISSN: 0278-0240 [Print] United States
PMID18219094 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • BIRC5 protein, human
  • Inhibitor of Apoptosis Proteins
  • Microtubule-Associated Proteins
  • Neoplasm Proteins
  • Survivin
  • Serine Endopeptidases
  • matriptase
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms (chemistry, mortality, pathology)
  • Carcinoma, Ductal, Breast (chemistry, mortality, pathology)
  • Disease Progression
  • Female
  • Humans
  • Immunohistochemistry
  • Inhibitor of Apoptosis Proteins
  • Microtubule-Associated Proteins (analysis)
  • Middle Aged
  • Neoplasm Proteins (analysis)
  • Neoplasm Staging
  • Serine Endopeptidases (analysis)
  • Survivin
  • Tissue Array Analysis (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: